期刊文献+

糖尿病肾病患者APOA5-1131T/C基因多态性与同型半胱氨酸水平探讨

下载PDF
导出
摘要 目的探讨载脂蛋白A5基因(APOA5)-1131T/C基因多态性与糖尿病肾病患者同型半胱氨酸(Hcy)水平的相关性。方法用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)技术检测45例糖尿病肾病患者APOA5-1131T/C基因型;用AU2700型全自动生化分析仪检测Hcy水平。结果糖尿病肾病组APOA5-1131T/C基因频率、等位基因频率与对照组差异无统计学意义(P>0.05)。糖尿病肾病组C等位基因携带者同型半胱氨酸水平显著高于非C等位基因携带者,差异有统计学意义(P<0.05)。结论 APOA5-1131T/C基因多态性对糖尿病肾病患者同型半胱氨酸水平有一定影响,C等位基因与糖尿病肾病患者同型半胱氨酸水平有密切关系。
出处 《中国医药指南》 2012年第12期543-544,共2页 Guide of China Medicine
  • 相关文献

参考文献2

二级参考文献11

  • 1李向平,赵水平,聂赛.载脂蛋白A5-1131T>C基因多态性与冠心病的关系[J].中国循环杂志,2007,22(1):4-8. 被引量:9
  • 2翟光华,闻平,郭兰芳,陈璐.Ⅱ型糖尿病患者APOA5-1131T/C基因多态性与血脂代谢和胰岛素抵抗的关系研究[J].遗传,2007,29(5):541-546. 被引量:12
  • 3Cleeman JI. Executive summary of the third report of the National Cholesterol of Education Program (NCEP) expert panel on detection,and treatment of high blood cholesterol in adults (Adult Treatment Panel 3)[J]. JAMA,2001,285(3) :2486-2497.
  • 4Kao JT, Wen HC, Chien KL,et al. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia[J]. Human Molecular Genetics, 2003,12 (19) : 2533-2539.
  • 5Pennacchio LA, Olivier M, Hubacek JA, et al. Two independent apolipoprotein A5 haplotypes influence human triglyceride levels[J]. Hum Mol Genet,2002, 11 (24):3031-3038.
  • 6Endo K, Yanagi H,Araki J,et al. Association found between the promotor region polymorphism in the apolipoprotein A-V gene and serum triglyceride level in Japanese school children[J]. Hum Genet,2002,111 (6) :570-572.
  • 7Frank G, Schaap, Patrick C, et al. APOAV reduces plasma triglyc erides by inhibiting very low density lipopmtein-triglyceride (VLDL-TG) production and stimulating lipopmtein lipase-mediated VLDL-TG hydrolysis [J].Biochemistry and Molecular Biological,2005,279 (27) :27941-27947.
  • 8Martin M ,Britta L,Malte K,et al. Apolipopmtein A5 accelerates plasma hydrolysis of triglyceride-rich lipopmteins by interaction with proteoglycan bound lipoprotein lipase[J]. Biochemistry and Molecular Biological,2005,17 : 1-21.
  • 9Baroukh N, Bauge E, Akiyama J,et al. Analysis of apolipoprotein A5, C3, and plasma triglyc-eride concentrations in genetically engineered mice[J].Arterioscler Thromb Vasc Biol, 2004, 24 (7):1297- 1302.
  • 10Fruchart-Najib J, Bauge E, NicuIescu LS, et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein As[J]. Biochem Biophys Res Commun, 2004,319 (2) : 397-404.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部